Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Juan De la camara"'
2
Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer
Autor: Antia, Cousillas Castineiras, Elena, Gallardo Martin, Ana, Fernandez Montes, Marta, Carmona Campos, Marta, Covela Rua, Mercedes, Salgado Fernandez, María Luz, Pellon Augusto, Nieves, Martínez Lago, Yolanda, Vidal Insua, Elena, Brozos Vazquez, Juan, De La Camara, Ana, Alonso Herrero, Jose Carlos, Mendez Mendez
Publikováno v: Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
The neutrophil-to-lymphocyte ratio (NLR) is an accessible marker from a routine blood test. This study explored the prognostic and predictive value of a change in NLR (c-NLR) after chemotherapy, baseline NLR (bNLR) and chemotherapy response, in metas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e877eaf1b27ee8fedecb2b7d2f8b4442
https://pubmed.ncbi.nlm.nih.gov/34761627
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Concordance between blood- and tumor-based detection of RAS mutations to guide therapy in metastatic colorectal cancer
Autor: Marta Covela Rúa, Juan De la camara, Yolanda Vidal, Ana Montes, Sonia Candamio Folgar, Isabel Ferreirós, Laura Muinelo, Rosa López, Maria Francisca Vazquez, Ramón Lago, Elena Brozos, Cristina Romero Blanco, Rafael López
Publikováno v: Journal of Clinical Oncology. 38:217-217
217 Background: The study of RAS using circulating tumor DNA (ctDNA) provides a good alternative for the detection and monitoring of RAS mutations during therapy course. Liquid biopsy has the advantage of being less invasive than conventional tissue
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b719da3adecd2767ef8ea60d6287e8b3
https://doi.org/10.1200/jco.2020.38.4_suppl.217
Zobrazit plný text záznamu
5
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study
Autor: Paula Jiménez-Fonseca, R. Vera, Patricia Ramírez, Manuel Sánchez-Cánovas, Elena Gallardo, Juan De la camara, Javier Gallego, Margarita Reboredo, Inmaculada Alés-Díaz, Paula González, Nuria Ruiz-Miravet, Carlos F. Lopez, Cristina Llorca, Carmen Guillén, Andrés Muñoz, Roberto Pazo-Cid, Ana María Fernández, Mamen Cañabate, Jorge Adeva, Adelaida García, Elvira Buxó, Víctor Navarro-Pérez, Guillermo Quintero, Luis Jesús López, Alberto Carmona-Bayonas, Mercedes Salgado
Publikováno v: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
BMC Cancer
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
Background: Treatment with nab-paclitaxel plus gemcitabine increases survival in patients with metastatic pancreatic cancer. However, the assessment of treatment efficacy and safety in non-selected patients in a real-life setting may provide useful i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26323259b3ceea687237138c50f0db8
http://zaguan.unizar.es/record/76952
Zobrazit plný text záznamu
6
Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation Study
Autor: Sonia Candamio Folgar, Alicia Abalo, Lorena Alonso-Alconada, Juan De la camara, Mª José Villanueva Villanueva Silva, Ana M. Fernandez, Yolanda Vidal Insua, Elena Brozos Vazquez, Miguel Abal, Jorge Barbazan, Laura Muinelo-Romay, Francisca Vázquez Rivera, Rafael López-López
Publikováno v: International Journal of Molecular Sciences; Volume 18; Issue 6; Pages: 1265
International Journal of Molecular Sciences, Vol 18, Iss 6, p 1265 (2017)
International Journal of Molecular Sciences
Colorectal cancer (CRC) is one of the major causes of cancer-related deaths. Early detection of tumor relapse is crucial for determining the most appropriate therapeutic management. In clinical practice, computed tomography (CT) is routinely used, bu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6a6dd64de76977ef05ade39d6fee8d8
Zobrazit plný text záznamu
8
Akademický článek
Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
Autor: Nieves Martínez-Lago, Teresa Calleja Chucla, Beatriz Alonso De Castro, Rafael Varela Ponte, Cristina Reboredo Rendo, Martin Igor Gomez-Randulfe Rodriguez, Sofia Silva Diaz, Begoña Graña Suarez, Juan de la Cámara Gomez, Fernando Busto Fernández, María Mateos Salvador, Margarita Reboredo Lopez
Publikováno v: Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract We evaluated the efficacy and safety of trifluridine/tipiracil (TAS-102) plus bevacizumab in treating refractory metastatic colorectal cancer (mCRC) in a retrospective, observational study. Patients refractory or intolerant to standard thera
Externí odkaz: https://doaj.org/article/c57ed14ff76941199d651c58407ca464
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje